Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study

Reproductive Biology and Endocrinology

Nicolas H. Zech⁴  Dietmar Spitzer³  Milena Králícková⁵  Tomáš Kohoutek¹  Libor Hradecký¹  Jasmin Okhowat⁴  Astrid Stecher⁴  Pierre Vanderzwalmen²  Maximilian Schuff⁴  Barbara Wirleitner⁴ 

[1] IVF Centers Prof. Zech, B. Smetany 2, Pilsen, 30100, Czech Republic;Centre Hospitalier Inter Régional Edith Cavell (CHIREC), Braine-l’Alleud, Bruxelles, Belgium;IVF Centers Prof. Zech, Innsbrucker Bundesstr. 35, Salzburg, 5020, Austria;IVF Centers Prof. Zech, Römerstrasse 2, Bregenz, 6900, Austria;Department of Histology and Embryology, Charles University in Prague – Faculty of Medicine in Pilsen, Karlovarská 48, Pilsen, 30166, Czech Republic

关键词: IVF;    Birth rate;    Blastocyst transfer;    Implantation;    Intrauterine hCG supplementation;   

Others  :  1217090
DOI  :  10.1186/s12958-015-0069-1

 received in 2015-03-04, accepted in 2015-06-19,  发布年份 2015

【 摘 要 】

Background

Successful embryo implantation depends on a well-timed maternal-embryonic crosstalk. Human chorionic gonadotropin (hCG) secreted by the embryo is known to play a key role in this process and to trigger a complex signal transduction cascade allowing the apposition, attachment, and invasion of the embryo into the decidualized uterus. Production of hCG was reported to be dependent on blastocyst quality and several articles suggested that intrauterine hCG injection increases pregnancy and implantation rates in IVF patients. However, no study has as yet analysed birth rates as final outcome. Our objective was to determine whether clinical outcome after blastocyst transfer can be improved by intrauterine injection of hCG and whether this is dependent on blastocyst quality.

Methods

A prospective randomised study was conducted in two settings. In cohort A, hCG application was performed two days before blastocyst transfer. In cohort B, the administration of hCG occurred just prior to embryo transfer on day 5. For both cohorts, patients were randomised to either intrauterine hCG application or to the control group that received culture medium. Clinical outcome was analysed according to blastocyst quality of transferred embryos.

Results

The outcome of 182 IVF-cycles (cohort A) and 1004 IVF-cycles (cohort B) was analysed. All patients received a fresh autologous blastocyst transfer on day five. Primary outcomes were pregnancy rates (PR), clinical pregnancy rates (cPR), miscarriage rates (MR), and live birth rates (LBR). No improvement of clinical outcome after intrauterine hCG administration on day 3 (cohort A) or day 5 (cohort B) was found, independently of blastocyst quality transferred. The final outcome in cohort A: LBR after transfer of top blastocysts was 50.0 % with hCG and 53.3 % in the control group. With non-top blastocysts, LBR of 17.1 % (hCG) and 18.2 % (control) were observed (n.s.). In cohort B, LBR with top blastocysts was 53.3 % (hCG) and 48.4 % (control), with non-top blastocysts it came to 28.7 % (hCG) and 35.0 % (control). The differences between the groups were statistically not significant. Furthermore, we investigated a possible benefit of hCG administration in correlation with female age. In both age groups (<38 years and ≥ 38 years) we found similar LBR after treatment with hCG vs. medium. A LBR of 47.1 % vs. 48.7 % was obtained in the younger group and 26.6 % vs. 30.8 % in the older group.

Conclusions

In contrast to previous studies indicating a substantial benefit from intrauterine hCG application in cleavage stage embryo transfers, in our study we could not find any evidence for improvement of clinical outcome in blastocyst transfer cycles, neither with top nor with non-top quality morphology.

【 授权许可】

   
2015 Wirleitner et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Koot YE, Boomsma CM, Eijkemans MJ, Lentjes EG, Macklon NS. Recurrent pre-clinical pregnancy loss is unlikely to be a ‘cause’ of unexplained infertility. Hum Reprod. 2011; 26:2636-41.
• [2]Ord T. The scourge: moral implications of natural embryo loss. Am J Bioeth. 2008; 8:12-9.
• [3]Fluhr H, Bischof-Islami D, Krenzer S, Licht P, Bischof P, Zygmunt M. Human chorionic gonadotropin stimulates matrix metalloproteinases-2 and −9 in cytotrophoblastic cells and decreases tissue inhibitor of metalloproteinases-1, −2, and −3 in decidualized endometrial stromal cells. Fertil Steril. 2008; 90:1390-5.
• [4]Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010; 8:102. BioMed Central Full Text
• [5]Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, Perrier d’Hauterive S. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol. 2010; 85:93-8.
• [6]Tapia-Pizarro A, Argandoña F, Palomino WA, Devoto L. Human chorionic gonadotropin (hCG) modulation of TIMP1 secretion by human endometrial stromal cells facilitates extravillous trophoblast invasion in vitro. Hum Reprod. 2013; 28:2215-27.
• [7]Bourdiec A, Calvo E, Rao CV, Akoum A. Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin: possible involvement in early embryo implantation. PLoS One. 2013; 22(8):e64829.
• [8]Edwards RG. Chorionic gonadotrophin, genes and embryonic signals regulating the implantation window. Reprod Biomed Online. 2007; 14:538-40.
• [9]Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod. 1988; 3:909-14.
• [10]Dokras A, Sargent IL, Barlow DH. Human blastocyst grading: an indicator of developmental potential? Hum Reprod. 1993; 8:2119-27.
• [11]Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES et al.. Uterine selection of human embryos at implantation. Sci Rep. 2014; 4:3894.
• [12]Riboldi M, Barros B, Piccolomini M, Alegretti JR, Motta ELA, Serafini PC. Does the intrauterine administration of rhCG before vitrified blastocysts transfer improves the potential of pregnancies when using blastocysts of inferior morphological grading? Fertil Steril. 2013; 100 Supplement:S289.
• [13]Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol. 2007; 269:85-92.
• [14]Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med. 2001; 19:37-47.
• [15]Sálker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T et al.. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One. 2010; 21(5):e10287.
• [16]Paiva P, Hannan NJ, Hincks C, Meehan KL, Pruysers E, Dimitriadis E et al.. Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity. Hum Reprod. 2011; 26:1153-62.
• [17]Srivastava A, Sengupta J, Kriplani A, Roy KK, Ghosh D. Profiles of cytokines secreted by isolated human endometrial cells under the influence of chorionic gonadotropin during the window of embryo implantation. Reprod Biol Endocrinol. 2013; 11:116. BioMed Central Full Text
• [18]Racicot KE, Wünsche V, Auerbach B, Aldo P, Silasi M, Mor G. Human Chorionic Gonadotropin Enhances Trophoblast-Epithelial Interaction in an In Vitro Model of Human Implantation. Reprod Sci. 2014; 21:1274-80.
• [19]Mansour R, Tawab N, Kamal O, El-Faissal Y, Serour A, Aboulghar M et al.. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril. 2011; 96:1370-4.
• [20]Zarei A, Parsanezhad ME, Younesi M, Alborzi S, Zolghadri J, Samsami A et al.. Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial. Iran J Reprod Med. 2014; 12:1-6.
• [21]Santibañez A, García J, Pashkova O, Colín O, Castellanos G, Sánchez AP et al.. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study. Reprod Biol Endocrinol. 2014; 12:9. BioMed Central Full Text
• [22]Rebolloso MM, Rosales De Leon JC, Galache Vega P, Santos-Haliscak R, Diaz-Spindola P, Gonzalez Vega O. Do intrauterine injection of human chorionic gonadtropin (hcg) before embryo transfer increases implantation and pregnancy rates in patients undergoing in vitro fertilization? Fertil Steril. 2013; 100 Supplement:S289.
• [23]Zech NH, Lejeune B, Stecher A, Puissant F, Vanderzwalmen S, Zech H et al.. A prospective evaluation on the optimal time for selecting a single embryo for transfer: day 3 versus day 5. Fertil Steril. 2007; 88:244-6.
• [24]Vanderzwalmen P, Hiemer A, Rubner P, Bach M, Neyer A, Stecher A et al.. Blastocyst development after intracytoplasmic morphologically selected sperm injection (IMSI) is directly correlated with the morphological integrity of human sperm nuclei. Reprod Biomed Online. 2008; 17:617-27.
• [25]Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000; 73:1155-8.
• [26]Spitzer D, Haidbauer R, Corn C, Stadler J, Wirleitner B, Zech NH. Effects of embryo transfer quality on pregnancy and live birth delivery rates. J Assist Reprod Genet. 2012; 29:131-5.
• [27]Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD et al.. Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized double-blind, placebo-controlled trial. Fertil Steril. 2014; 102:1591-5.
• [28]Woodward BJ, Lenton EA, Turner K. Human chorionic gonadotrophin: embryonic secretion is a time-dependent phenomenon. Hum Reprod. 1993; 8:1463-68.
• [29]Butler SA, Luttoo J, Freire MO, Abban TK, Borrelli PT, Iles RK. Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment. Reprod Sci. 2013; 20:1038-45.
• [30]Xiao-Yan C, Jie L, Dang J, Tao L, Xin-Ru L, Guang-Lun Z. A highly sensitive electrochemiluminescence immunoassay for detecting human embryonic human chorionic gonadotropin in spent embryo culture media during IVF-ET cycle. J Assist Reprod Genet. 2013; 30:377-82.
• [31]Wang H, Zhang R, Han D, Liu C, Cai J, Bi Y et al.. Association of human chorionic gonadotropin level in embryo culture media with early embryo development. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34:1039-41.
• [32]Thompson SM, Onwubalili N, Brown K, Jindal SK, McGovern PG. Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (eSET): a national study. J Assist Reprod Genet. 2013; 30:1577-81.
• [33]Ahlström A, Westin C, Reismer E, Wikland M, Hardarson T. Trophectoderm morphology: an important parameter for predicting live birth after single blastocyst transfer. Hum Reprod. 2011; 26:3289-96.
• [34]Desai J, Holt-Shore V, Torry RJ, Caudle MR, Torry DS. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod. 1999; 60:887-92.
• [35]Macklon NS, Brosens JJ. The Endometrium as a Sensor of Embryo Quality. Biol Reprod. 2014; 91:98.
• [36]Van den Abbeel E, Balaban B, Ziebe S, Lundin K, Cuesta MJ, Klein BM et al.. Association between blastocyst morphology and outcome of single-blastocyst transfer. Reprod Biomed Online. 2013; 27:353-61.
• [37]Eftekhar M, Rahmani E, Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles. Int J Fertil Steril. 2012; 6:175-8.
• [38]Ben-Meir A, Aboo-Dia M, Revel A, Eizenman E, Laufer N, Simon A. The benefit of human chorionic gonadotropin supplementation throughout the secretory phase of frozen-thawed embryo transfer cycles. Fertil Steril. 2010; 93:351-4.
• [39]Bernardini L, Moretti-Rojas I, Brush M, Rojas FJ, Balmaceda JP. Failure of hCG/LH receptors to stimulate the transmembrane effector adenylyl cyclase in human endometrium. Adv Biosci Biotechnol. 2013; 4:949-57.